Untitled Post

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial 20 patients were treated, 16 patients (unmatched, nonrandomized) were controls, 6 treated patients lost to followup, in some cases due to worsening Update:  on March 25, India banned the export of hydroxychloroquine.  And has approved its use prophylactically: “The…

This NEJM Article points out that, although, “Drug labels are written by drug companies, then negotiated and approved by the FDA,” still, “information gets lost between FDA review and the approved label.” What often gets lost is data on harms due to the drug. Several examples are included, and it turns out that two popular…

UPDATE:  This is a 2006 article.  Sorry. Too bad we have to get our science from the Mail, but in the era of Conflicts of Interest, maybe it isn’t so strange that we read about the flip side of pharmaceuticals from media outlets that don’t rely on pharmaceutical company advertising to survive. New American research…

CDC issued a new poster Friday night October 24, which admits Ebola may in fact be airborne. But CDC says it doesn’t travel farther than 3 feet.  Well, at least CDC is starting to move the narrative.  Maybe tomorrow it will be 5 feet.  Then 10.  Maybe next month they will tell us why all…

 https://www.youtube.com/watch?v=wPbxOeYAC7s

First, access to hydroxychloroquine and chloroquine was restricted.  The chloroquine drugs only work during active viral replication. While extremely safe at prescribed doses, and used daily for years by hundreds of thousands of patients with rheumatoid arthritis or lupus, overdose can be fatal. Awareness of these facts led to the FDA restricting the use of…